Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-08-30

Clinical Trial Update: Disulfiram Combined With Lorazepam for Alcohol Dependence and Anxiety Disorder [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating disulfiram combined with lorazepam for alcohol dependence and anxiety disorder with completed status and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Disulfiram (Disulfiram)
  • Lorazepam (Lorazepam)

Snippet

Sponsor: University of New Mexico | Conditions: Alcohol Dependence, Anxiety Disorder | Phase 4 | Status: COMPLETED | Results posted: 2023-08-30